Snowden Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Snowden Capital Advisors's LMAT Position: Q2 2026 in Review
Snowden Capital Advisors reduced its LeMaitre Vascular (LMAT) stake by 18% in Q2 2026, selling an estimated $98.1K and leaving 4,238 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #936.
Snowden Capital Advisors first reported a position in LMAT in Q2 2022 and has held it in 17 quarters since. The position peaked at $713K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Snowden Capital Advisors held 4,238 shares of LeMaitre Vascular worth $407K as of Q2 2026.
- Snowden Capital Advisors sold 957 LeMaitre Vascular shares in Q2 2026, an estimated $98.1K.
- LeMaitre Vascular made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #936 holding.
- Snowden Capital Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 17 quarters since.
- Snowden Capital Advisors's LeMaitre Vascular position peaked at $713K in Q4 2024.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.